Toggle Nav
$2,890.00

U266 SMAD/TGFbeta Reporter (Luc) stable cell line

Catalog number
CL-1476
Description
U266 SMAD/TGFbeta Reporter (Luc) cells are derived from the human myeloma U266 cell line by stably integration of a SMAD/TGFbeta firefly luciferase reporter construct. The U266 cells are an important tool in studying the pathogenesis, progression, and treatment of multiple myeloma, as well as for testing chemotherapies and immunotherapies, including monoclonal antibodies, immune checkpoint inhibitors, and CAR-T cell therapies. U266 SMAD/TGFbeta Reporter (Luc) cells stably express firefly luciferase under the control of the SMAD/TGFbeta response elements, can be used for monitoring the activity of TGF?/SMAD signaling pathway.
U266 SMAD/TGFbeta Reporter (Luc) stable cell line
Product Details

Product Details

Package Size 2 x 10^6 cells
Parental cell line U266 cells
Transgenic gene Firefly luciferase
Mammalian selection Puromycin
Biosafety level 2
Storage Liquid nitrogen
Availability 3-4 weeks
Shipping condition dry ice

Premade Stable Cell Lines

  1. GFP-Firefly luciferase control cell lines
  2. RFP-Firefly luciferase control cell lines
  3. Fluorescent control cell lines
  4. Firefly luciferase control cell lines
  5. Signaling pathway reporter cell lines
  6. Cre stable cell lines
Copyright © 2025, FenicsBIO. All rights reserved.